Author

M. Toma

University Hospital Bonn

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Research Focus:differential expression· 2 Organism:human· 2 Organism:mouse· 2 Assay:scRNA-seq· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

A. Abdollahi· 1 shared A. Dubrovska· 1 shared A. Franken· 1 shared A. Heine· 1 shared A. Linge· 1 shared A. Mukha· 1 shared A. Schlitzer· 1 shared Alina Hunecke· 1 shared

Activity by Year

2021-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Abdollahi

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Human chronic inflammation is orchestrated by spatially restricted inflammation-activated Dendritic cells

Jake R. Thomas, Jessica Haub, Alina Hunecke, Jiangyan Yu, P. Maier, M. Zhang, B.E.F. Pregler, Markus Raspe, S. Strieth, M. Schneider, V. Schäfer, C. Pizzaro, D. Skowasch, Florent Ginhoux, M. Toma, , A. Schlitzer

This study identifies a novel inflammation-associated dendritic cell state in human chronic inflammation and shows its spatial restriction and therapeutic relevance.

bioRxiv · May 19, 2025 · PreprintImmunology

The CCR4/CCL17 axis drives intestinal acute Graft versus Host disease after allogeneic bone marrow transplantation

S. Schlaweck, M. Klesse, O. Schanz, S. K. Jorch, G. Kristiansen, M. Toma, C. Flores, J. Becker-Gotot, C. Kurts, P. Brossart, D. Wolf, A. Heine

This study shows that the CCR4/CCL17 axis promotes intestinal acute GvHD by recruiting T cells and increasing Gata3 expression, and identifies ruxolitinib as a potential therapeutic.

bioRxiv · Mar 2, 2024 · PreprintImmunology

IL-1R signaling drives enteric glia-macrophage interactions in colorectal cancer

L. van Baarle, V. De Simone, L. Schneider, S. Santhosh, S. Abdurahiman, F. Biscu, R. Schneider, L. Zanoletti, S. Verbandt, Z. Hu, M. Stakenborg, B.-J. Ke, B. Garcia-Reyes, J. Henn, M. Toma, , G. Matteoli

This study identifies IL-1R signaling as a driver of enteric glia-macrophage interactions in colorectal cancer, promoting tumor progression through IL-6 secretion.

bioRxiv · Jun 1, 2023Cancer Biology

GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy

A. Mukha, U. Kahya, A. Linge, O. Chen, S. Lock, V. Lukiyanchuk, S. Richter, T. C. Alves, M. Peitzsch, V. Telychko, S. Skvortsov, G. Negro, B. Aschenbrenner, I.-I. Skvortsova, P. Mirtschink, , A. Dubrovska

This study shows that glutamine catabolism via GLS regulates redox state, stemness, and autophagy in prostate cancer, affecting radiosensitivity and patient outcomes.

bioRxiv · Jan 7, 2021Cancer Biology